Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meredith M Regan

Showing results (91-100 of 260) with videos related to

Pageof 26
Sort By:
BJU International|January 11, 2008
Response to docetaxel/carboplatin-based chemotherapy as first- and second-line therapy in patients with metastatic hormone-refractory prostate cancerMari Nakabayashi, Oliver Sartor, Susanna Jacobus, et al.
The Journal of Urology|October 1, 2013
Measuring and predicting prostate cancer related quality of life changes using EPIC for clinical practiceJonathan J Chipman, Martin G Sanda, Rodney L Dunn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Minimal effect of a low-fat/high soy diet for asymptomatic, hormonally naive prostate cancer patientsDimitrios Spentzos, Christos Mantzoros, Meredith M Regan, et al.
JCO Oncology Practice|July 14, 2025
Long-Term Performance of Prognostic Models for Advanced Renal Cell Carcinoma in the Era of Improved Survival With Immune Checkpoint InhibitorsCharlene M Mantia, Opeyemi A Jegede, David F McDermott, et al.
JAMA Network Open|May 12, 2026
Stage IV Breast Cancer Incidence and Survival, 2010-2021Jorge Avila, Julieta Leone, Nabihah Tayob, et al.
Immunotherapy|September 4, 2018
Sequential treatment approaches in  the management of BRAF wild-type advanced melanoma: a cost-effectiveness analysisAhmad Tarhini, Agnes Benedict, David McDermott, et al.
International Journal of Radiation Oncology, Biology, Physics|April 18, 2026
Treatment-Free Survival: A Novel Endpoint in Trials of Stereotactic Body Radiation With or Without Systemic TherapyDavid J Einstein, Ronald C Chen, Karen E Hoffman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Inherited variation in the androgen pathway is associated with the efficacy of androgen-deprivation therapy in men with prostate cancerRobert W Ross, William K Oh, Wanling Xie, et al.
The American Journal of Clinical Nutrition|July 30, 2002
Lysine requirements of healthy adult Indian subjects receiving long-term feeding, measured with a 24-h indicator amino acid oxidation and balance techniqueAnura V Kurpad, Meredith M Regan, Tony Raj, et al.
JNCI Cancer Spectrum|April 28, 2020
Independent Validation of EarlyR Gene Signature in BIG 1-98: A Randomized, Double-Blind, Phase III Trial Comparing Letrozole and Tamoxifen as Adjuvant Endocrine Therapy for Postmenopausal Women With Hormone Receptor-Positive, Early Breast CancerSteven A Buechler, Kathryn P Gray, Yesim Gökmen-Polar, et al.
Pageof 26

Showing results (91-100 of 260) with videos related to

Sort By:
Pageof 26
BJU International|January 11, 2008
Response to docetaxel/carboplatin-based chemotherapy as first- and second-line therapy in patients with metastatic hormone-refractory prostate cancerMari Nakabayashi, Oliver Sartor, Susanna Jacobus, et al.
The Journal of Urology|October 1, 2013
Measuring and predicting prostate cancer related quality of life changes using EPIC for clinical practiceJonathan J Chipman, Martin G Sanda, Rodney L Dunn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Minimal effect of a low-fat/high soy diet for asymptomatic, hormonally naive prostate cancer patientsDimitrios Spentzos, Christos Mantzoros, Meredith M Regan, et al.
JCO Oncology Practice|July 14, 2025
Long-Term Performance of Prognostic Models for Advanced Renal Cell Carcinoma in the Era of Improved Survival With Immune Checkpoint InhibitorsCharlene M Mantia, Opeyemi A Jegede, David F McDermott, et al.
JAMA Network Open|May 12, 2026
Stage IV Breast Cancer Incidence and Survival, 2010-2021Jorge Avila, Julieta Leone, Nabihah Tayob, et al.
Immunotherapy|September 4, 2018
Sequential treatment approaches in  the management of BRAF wild-type advanced melanoma: a cost-effectiveness analysisAhmad Tarhini, Agnes Benedict, David McDermott, et al.
International Journal of Radiation Oncology, Biology, Physics|April 18, 2026
Treatment-Free Survival: A Novel Endpoint in Trials of Stereotactic Body Radiation With or Without Systemic TherapyDavid J Einstein, Ronald C Chen, Karen E Hoffman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Inherited variation in the androgen pathway is associated with the efficacy of androgen-deprivation therapy in men with prostate cancerRobert W Ross, William K Oh, Wanling Xie, et al.
The American Journal of Clinical Nutrition|July 30, 2002
Lysine requirements of healthy adult Indian subjects receiving long-term feeding, measured with a 24-h indicator amino acid oxidation and balance techniqueAnura V Kurpad, Meredith M Regan, Tony Raj, et al.
JNCI Cancer Spectrum|April 28, 2020
Independent Validation of EarlyR Gene Signature in BIG 1-98: A Randomized, Double-Blind, Phase III Trial Comparing Letrozole and Tamoxifen as Adjuvant Endocrine Therapy for Postmenopausal Women With Hormone Receptor-Positive, Early Breast CancerSteven A Buechler, Kathryn P Gray, Yesim Gökmen-Polar, et al.
Pageof 26